BioSpace News Archive

GEOS is taking healthcare safety in a new direction, by integrating campus and remote site safety into one proactive solution.

Global organization calls for urgent investment as famine prevention funding stalls

Stratus Pharmaceuticals, Inc. and Tarmac Products, Inc. are pleased to announce that the U.S. Food and Drug Administration (FDA) inspected and approved its Miami Gardens manufacturing facility to be GMP (Good Manufacturing Practices) compliant.

Purdue Pharma L.P. announced that John Renger, Ph.D., has been appointed Vice President, Head of Research & Development and Regulatory Affairs.

TCR2 Therapeutics Inc., an immuno-oncology company pioneering a novel class of T cell receptor (TCR)-based cellular therapies for solid tumors and blood cancers, announced today that new preclinical data on its TRuC™ platform and its lead solid tumor program TC-210 will be presented at the American Association for Cancer Research (AACR) 2018 Annual Meeting to be held April 14-18, 2018 in Chicago, IL.

Pipeline Corner Presentation, Mini Oral Sessions and Paper Poster Session to take place April 22-23

SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using Human Dermal Fibroblasts, has filed an Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA) to expand its study of CybroCell Human Dermal Fibroblasts to treat degenerative disc disease.

On Saturday and Sunday, Mar. 24 and 25, the Saddleback Spring Classic Gran Fondo and the 20th Anniversary Reaching for the Cure Half Marathon, 10K, 5K and Kids Run was held on the Irvine Valley College campus with contributions totaling over $530,000 to help reach for a cure for pediatric cancer.

The first in-human robotic bronchoscopy in the United States is performed.

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2018 results on Tuesday, May 8, 2018.